Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19

This retrospective cohort study (n=966) found convalescent plasma treatment was associated with improved 30-day mortality among patients with haematological cancers hospitalised for COVID-19 vs untreated control patients (adjusted HR 0.60; 95% CI 0.37-0.97).

JAMA Oncology